Showing results (501-510 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|January 27, 2015
Linkage to and engagement in HIV care in western Kenya: an observational study using population-based estimates from home-based counselling and testingBecky L Genberg, Violet Naanyu, Juddy Wachira, et al.
The Lancet. HIV|July 5, 2020
The usefulness of HIV partner services in the age of treatment as prevention: a registry-based studyChi-Chi N Udeagu, Sharmila Shah, Kavita Misra, et al.
The Lancet. HIV|November 10, 2022
Innovations, adaptations, and accelerations in the delivery of HIV services during COVID-19Eamonn Murphy, Meg Doherty, Wafaa El Sadr, et al.
The Lancet. HIV|November 12, 2022
Living with COVID-19 and preparing for future pandemics: revisiting lessons from the HIV pandemicJudith D Auerbach, Andrew D Forsyth, Calum Davey, et al.
The Lancet. HIV|August 7, 2021
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort studyWaasila Jassat, Cheryl Cohen, Stefano Tempia, et al.
The Lancet. HIV|August 2, 2021
Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studiesFeixue Wei, Michael M Gaisa, Gypsyamber D'Souza, et al.
The Lancet. HIV|September 12, 2021
Cancer risk in adolescents and young adults living with HIV in South Africa: a nationwide cohort studyYann Ruffieux, Tafadzwa Dhokotera, Mazvita Muchengeti, et al.
The Lancet. HIV|February 2, 2023
Potential health benefits of integrated screening strategies for alcohol, tobacco, other substance use, depression, anxiety, and chronic pain among people living with HIV in the USA: a mathematical modelling studyAnna Bershteyn, Emma Richard, Qinlian Zhou, et al.
The Lancet. HIV|February 12, 2023
Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGEhIV cohort studyEveline Verheij, Anders Boyd, Ferdinand W Wit, et al.
The Lancet. HIV|November 28, 2025
Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort studyJean Bernard Marc, Caitlyn McCarthy, Carole L Wallis, et al.
Pageof 79